课题基金 / 基金详情

Expediting the drug approval process in oncology through access with evidence development schemes

Expediting the drug approval process in oncology through access with evidence development schemes
通过证据开发计划加快肿瘤学药物审批流程
批准号：
445284
负责人：
Heath Anna
金额：
$25.36万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-04-01 至 2024-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=445284&lang=en
关键词：
Market Access With Evidence Development Novel Cancer Therapies Reimbursement Decision Making Research Design And Prioritisation Routinely Collected Health Data Value Of Information

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The process of approving new drugs to treat cancer can be time-consuming and expensive, which prevents universal access to life-extending/life-saving treatments. Researchers have proposed a process for approving drugs that reduces the time between their i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金